I was wondering whether anyone could suggest sources of information about amplified genes in cancer, especially if the website tries to combine it with (over)expression information. We wrote a review on amplified and expressed genes recently and are trying to get a sense of what else is out there, so that when we update it we make sure we get different sources of information, not just a search of the literature.
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
It would be helpful if you listed the sources that you already have (for the benefit of other users who find this thread and to prevent duplication of resources you are already aware of).
That being said some resources that spring to mind are listed below. Mostly these are initiatives that have created or are in the process of creating data that would provide both amplification and expression data, via next generation whole genome shotgun (WGS) and RNA sequencing (RNA-seq) or copy-number + expression microarrays.
Oncomine [registration required]
The Cancer Genome Anatomy Project (CGAP)
The Cancer Genome Characterization Initiative (CGCI; may soon have relevant data)
The Cancer Genome Atlas (TCGA; relevant data gradually entering the public domain)
The international cancer genome consortium (ICGC)
The database of genomic variants
-
Here is a list of the ones we have got already- CONAN (http://www.sanger.ac.uk/cgi-bin/gene...nan/search.cgi)
- Cancer Genome Workbench (https://cgwb.nci.nih.gov/)
- Breast (http://www.itb.cnr.it/breastcancer/)
- Integrative Oncogenomics Cancer Browser - IntOGen (http://www.intogen.org/)
- Oncomine (http://www.oncomine.org/)
Oh, and of course there is our website too: http://amplicon.icr.ac.ukLast edited by danielsbrewer; 09-23-2010, 12:40 AM.
Comment
-
We've put together a resource which allows one to query for over-expression and amplification in Cancer genomics samples, particularly those profiled by The Cancer Genome Atlas.
Here are some related threads if you're interested:
Registered SEQanswers sponsors/vendors can post commercial content here. Please support our sponsors!
Registered SEQanswers sponsors/vendors can post commercial content here. Please support our sponsors!
Good luck!
------------------------------
GenePool is making genomics data management, analysis, and sharing easier!
Products @ www.stationxinc.comLast edited by GenePool; 11-23-2014, 09:26 PM.
Comment
Latest Articles
Collapse
-
by seqadmin
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...-
Channel: Articles
03-22-2024, 06:39 AM -
-
by seqadmin
The field of conservation genomics centers on applying genomics technologies in support of conservation efforts and the preservation of biodiversity. This article features interviews with two researchers who showcase their innovative work and highlight the current state and future of conservation genomics.
Avian Conservation
Matthew DeSaix, a recent doctoral graduate from Kristen Ruegg’s lab at The University of Colorado, shared that most of his research...-
Channel: Articles
03-08-2024, 10:41 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 03-27-2024, 06:37 PM
|
0 responses
15 views
0 likes
|
Last Post
by seqadmin
03-27-2024, 06:37 PM
|
||
Started by seqadmin, 03-27-2024, 06:07 PM
|
0 responses
13 views
0 likes
|
Last Post
by seqadmin
03-27-2024, 06:07 PM
|
||
Started by seqadmin, 03-22-2024, 10:03 AM
|
0 responses
55 views
0 likes
|
Last Post
by seqadmin
03-22-2024, 10:03 AM
|
||
Started by seqadmin, 03-21-2024, 07:32 AM
|
0 responses
70 views
0 likes
|
Last Post
by seqadmin
03-21-2024, 07:32 AM
|
Comment